Bookmark Website  | Free Registration  | The Team
The Lounge  | Champions  | The Wire |  Schedule |  Audio  |  Arcade  |  The Top Ten  |  Historical  |  Email  |  Video

Diet Pills and Consumer Fraud


Diet pills have met with many different fates, and come with many different promises. But at what point does the line between misleading advertising and outright fraud cross? And how long will health products be allowed to cross this line? Some diet pills have proven very effective, but were then found to have serious health side effects. Other diet pills have had short, explosive life spans. And some diet pills just plug right along. But one hallmark that remains true about the diet pill industry is that there's always some new "breakthrough" with a new set of promises that aren't easily verified.

Cortislim is one of newer generations of diet pills. Cortislim promised to reduce fat around the abdomen by reducing levels of the "stress hormone" cortisol. In October of 2004, the FTC charged the makers of Cortislim of claiming falsely and without substantiation, that their products can cause weight loss and reduce the risk of, or prevent, serious health conditions.

According to the FTC, the defendants began marketing CortiSlim in August 2003, through nationally disseminated infomercials featuring Cynaumon and Talbott that aired on a number of television channels, including Access Television, Travel Channel, and Discovery Channel. The FTC alleges that the defendants promoted cortisol control as "the answer" foranyone who wants to lose weight, especially abdominal weight. According to the FTC's complaint, the defendants' broadcast ads, print ads, and Web sites claimed that persistently elevated levels of cortisol, the "stress hormone," are the underlying cause of weight gain and weight retention and also claimed that CortiSlim effectively reduces and controls cortisol levels and thereby causes substantial weight loss. The FTC alleges that the defendants claimed that CortiSlim: (1) causes weight loss of 10 to 50 pounds for virtually all users; (2) causes users to lose as much as 4 to 10 pounds per week over multiple weeks; (3) causes users to lose weight specifically from the abdomen, stomach, and thighs; (4) causes rapid and substantial weight loss; (5) causes long-term or permanent weight loss; and (6) causes weight loss. The FTC also alleges that the defendants claimed that the effectiveness of CortiSlim and its ingredients is demonstrated by over 15 years of scientific research. According to the FTC's complaint, these claims are false or unsubstantiated.

Cortislim eventually withdrew their initial advertising, and adopted a tamer approach, but not before lawyers started collecting signatures for a class action suit alleging fraud.Which raises the fundamental question - how long will diet pills and other similar products be allowed to engage in questionable advertising?

Prescription drugs are required to pass many tests to prove their usefulness and safety. But with over the counter and herbal remedies, manufacturers can essentially claim whatever they want of their products without publishing any study results. This creates a scenario where companies nearly have a green light to make outrageous claims about diet products. The makers of Cortislim are said to have made $50 million.

But when the government puts a company in the crosshairs, other lawsuits are nearly always soon to follow. Within a few days of the Vioxx withdrawal, a class action suit was filed. These trends will continue, and if the FTC stays aggressive in pursuing false advertising, the incentives for bad marketing practices on unproven diet pills will decrease.

Rex Ryan maintains the website:

http://www.cortislimfacts.info


MORE RESOURCES:

PsychCentral.com

'Fat Shaming' Linked to Weight Gain, Not Weight Loss
PsychCentral.com
“Fat shaming” does not encourage weight loss in overweight adults; in fact, those who experience this type of discrimination tend to gain more weight, according to new research by University College London (UCL). In a four-year study of 2,944 UK adults ...
Fat shaming does not help with weight loss: StudyTech Times
Weight Discrimination Leads to Obesity Rather Than Weight LossGuardian Liberty Voice
Discriminating against obese 'doesn't help weight loss'BBC News
Science 2.0 -Headlines & Global News
all 159 news articles »


Retraining Yourself to Eat For Lasting Weight Loss Success (Part 3)
Bangor Daily News
Retraining yourself to eat for weight loss requires changes but you will be surprised how many things you're already doing that support weight loss. Despite what you may think, you don't have to change everything. Chances are good you have several or ...



Tech Times

FDA gave green light to weight loss pill Contrave. What you need to know
Tech Times
The drugs represent a middle ground in weight loss treatment. It's not as drastic as having surgery, but it's also more effective than just going on a diet. It combines two drugs, naltrexone and bupropion, that have already been approved by the FDA ...
FDA Approves New Weight-Loss PillNews Channel Daily

all 2 news articles »


Headlines & Global News

Health: New weight-loss drug approved
Houston Chronicle
The U.S. Food and Drug Administration announced the approval last week of the new weight-loss drug Contrave, a mix of antidepressant and alcohol dependence medications. The drug, intended to be used along with a low-calorie diet and exercise regimen, ...
FDA approves new weight-loss drugThe Journal News | LoHud.com
Orexigen: Poised To Grab A Large Part Of The Weight Loss MarketSeeking Alpha (registration)
FDA approves weight-loss drug ContraveHarvard Health Publications (blog)
Headlines & Global News -WRCB-TV
all 53 news articles »


Weight loss not the best indicator of health
Stockton Record
Almost daily at my gym I will see people step onto the scale to check their weight or I will hear them tell me their health and fitness goal is to lose weight. In short, there is too much focus on weight and not enough on fitness. Now, obesity is a ...

and more »


USA TODAY

Contrave, Newest Weight-Loss Option: FAQs
WebMD
Sept. 11, 2014 -- The FDA's approval on Wednesday of a new prescription weight-loss pill offers yet another option for the more than one-third of American adults who are obese. Called Contrave, the new drug is the third prescription weight-loss drug to ...
FDA Approves Contrave Weight Loss Drug From Orexigen And TakedaForbes
FDA approves a third new weight-loss pillUSA TODAY
FDA OKs weight-loss drugAlbany Times Union

all 261 news articles »


Facebook group for Carman alumni creates offshoot weight loss challenge
The Flint Journal
On and off the diet path for several years, she started seeing online posts by Ramona Wirostek-Ward about the creation of teams for a health challenge with competitors throughout the country and thought it could be fun. "We have teams and each team was ...



The Inquisitr

Which diet is best for long-term weight loss?
Boston Globe
Two new diet studies that appear to reach opposite conclusions on what works better for weight loss have left me scratching my head. Both were published last week in highly respected medical journals, but one found that following a high-fat, Atkins ...
Is Low-Carb Really King of Weight Loss?Huffington Post
Weight Loss: Is A Low Fat Or Low Carb Diet Best?The Inquisitr
Study: Low-carb diet beats low-fat for weight loss and heart healthGoErie.com
Examiner.com
all 72 news articles »


The Denver Channel

Extreme Weight Loss medical director blogs about Jeff & Juliana's weight loss ...
The Denver Channel
Editor's note: This is a blog from Dr. Holly Wyatt, the Medical Director for the University of Colorado's Anschutz Health and Wellness Center (AHWC) and ABC's Extreme Weight Loss. During season four of the reality TV show, participants started their ...

and more »


Fox News

8 common weight loss myths busted
Fox News
America seems to be getting fatter, so it's no wonder more emphasis is being placed on healthy lifestyle and weight loss. In general, this is a good thing—obesity is expensive and can be life-threatening. However, misinformation about obesity—and ...


Google News


Advertisement



Section Site Map - Submit News - Feedback - Comments - Advertise with Us

Copyright © 2006 Luminati Inc. All rights reserved.